BDBM711264 ((2-(3'-(6-((5- cyanopyridin-3- yl)methoxy)-5- (((2-hydroxyethyl) amino)methyl) benzo[d]oxazol- 2-yl)-2,2'-dimethyl- [1,1'-biphenyl]-3- yl)-6-(difluoromethoxy) benzo[d]oxazol-5- yl)methyl)-L-proline::US12187713, Example 120

SMILES Cc5c(c4cccc(c3nc2cc(CN1CCC[C@H]1C(=O)O)c(OC(F)F)cc2o3)c4C)cccc5c8nc7cc(CNCCO)c(OCc6cncc(C#N)c6)cc7o8

InChI Key InChIKey=IFPLGMLZICCHTK-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 711264   

TargetProgrammed cell death 1 ligand/protein 1(Human)
Betta Pharmaceuticals

US Patent
LigandPNGBDBM711264(((2-(3'-(6-((5- cyanopyridin-3- yl)methoxy)-5- ((...)
Affinity DataIC50: 1.10nMAssay Description:The assays were conducted in a standard black 384-well polystyrene plate with a final volume of 20 μL. Inhibitors were first serially diluted in DMSO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/19/2025
Entry Details
Go to US Patent